• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Obstetrics

Maternal deoxynivalenol exposure associated with adverse birth outcomes observed in China

byRhianna DavisandAlex Chan
September 4, 2023
in Obstetrics, Pediatrics, Public Health
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. Compared to those consuming below the maximum tolerable daily intake of the mycotoxin deoxynivalenol, those consuming above this threshold were at a greater risk of giving birth to small-for gestational age infants. 

Evidence rating level: 1 (Excellent)

Deoxynivalenol (DON) is a mycotoxin found in certain agricultural products, such as wheat and corn. It has been found to cause fetal growth retardation in animals, but its effects have not previously been studied in humans. Researchers aimed to assess the effect of DON consumption on fetal growth. 1538 participants were included in this prospective study via the Tongji Maternal and Child Health Cohort (TMCHC) in Wuhan, China. Liquid chromatography with tandem mass spectrometry were used to measure both total (tDON) and free (fDON) DON in urine during the second trimester, which was then used to infer the daily intake of DON. 35.9% of subjects were found to exceed the provisional maximum daily intake of DON, which is 1 µg/kg bw. After adjusting for confounding variables, greater urinary tDON was inversely associated with birth weight (adjusted β = -22.00 g, 95% CI: -37.11, -6.89). Compared to the lowest third of tDON concentrations, birth weight was decreased by 81.11 g (95% CI: -127.00, -35.23) for the highest third (p <0.001). Compared to those below the maximum tolerable daily intake, those above this threshold had offspring with lower birth weight (β = -79.79 g; 95% CI: -119.09, -40.49) and greater risk of small-for gestational age (SGA) (OR = 1.48; 95% CI: 1.02, 2.15). A limitation of this study is that there may be additional confounding variables that were not adjusted for, such as the consumption of toxins other than DON. Overall, this study suggests that stricter regulations on the levels of DON in food products should be enforced for the protection of fetal health. 

Click to read the study in BMC Medicine

Image: PD

©2023 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

The Scan by 2 Minute Medicine®: FDA clears Alzheimer’s blood test, WHO warns of antibiotic resistance, New York confirms chikungunya case, and CDC layoffs raise concern

2 Minute Medicine Rewind October 13, 2025

Punjab launches AI screening program this week

Tags: obstetricspediatricsprenatalpublic health
Previous Post

Partial resistance to artemisinins in malarial parasites increasing in Uganda

Next Post

Mediterranean diet adherence may be associated with improved cardiovascular health in adult women

RelatedReports

The Scan by 2 Minute Medicine®:  Ultra-Trail du Mont-Blanc, Taylor Swift, NBA rookie Chet Holmgren and Magic Mushrooms!
Infectious Disease

The Scan by 2 Minute Medicine®: FDA clears Alzheimer’s blood test, WHO warns of antibiotic resistance, New York confirms chikungunya case, and CDC layoffs raise concern

October 21, 2025
Weekly Rewinds

2 Minute Medicine Rewind October 13, 2025

October 13, 2025
Blindness and visual impairment decreasing worldwide
AI Roundup

Punjab launches AI screening program this week

September 30, 2025
FDA-approved weight loss medications associated with weight loss at one year
Chronic Disease

The association of the planetary health diet with type 2 diabetes incidence and greenhouse gas emissions: Findings from the EPIC-Norfolk prospective cohort study

September 23, 2025
Next Post
FDA-approved weight loss medications associated with weight loss at one year

Mediterranean diet adherence may be associated with improved cardiovascular health in adult women

The Scan by 2 Minute Medicine®:  Ultra-Trail du Mont-Blanc, Taylor Swift, NBA rookie Chet Holmgren and Magic Mushrooms!

The Scan by 2 Minute Medicine®: Wegovy: A Magic Bullet? Contending with Congenital Heart Disease, COVID-19 Developments, and Silently Spiked Straws

#VisualAbstract: Phase 3 Trial of Concizumab in Hemophilia with Inhibitors

#VisualAbstract: Phase 3 Trial of Concizumab in Hemophilia with Inhibitors

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • World Health Organization warns that one in six infections now antibiotic resistant
  • Ifinatamab Deruxtecan in Patients With Extensive-Stage Small-Cell Lung Cancer: Primary Analysis of the Phase 2 IDeate-Lung01 Trial
  • Artificial intelligence (AI) may reduce cognitive load for sonographers in fetal ultrasound scans without affecting diagnostic performance
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.